Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor
Authors:
- 30 April 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 8 (6) , 1291-1302
Abstract
The bone morphogenetic protein (BMP) signaling pathway has essential functions in development, homeostasis, and the normal and pathophysiologic remodeling of tissues. Small molecule inhibitors of the BMP receptor kinase family have been useful for probing physiologic functions of BMP signaling in vitro and in vivo and may have roles in the treatment of BMP-mediated diseases. Here we describe the development of a selective and potent inhibitor of the BMP type I receptor kinases, LDN-212854, which in contrast to previously described BMP receptor kinase inhibitors exhibits nearly 4 orders of selectivity for BMP versus the closely related TGF-β and Activin type I receptors. In vitro, LDN-212854 exhibits some selectivity for ALK2 in preference to other BMP type I receptors, ALK1 and ALK3, which may permit the interrogation of ALK2-mediated signaling, transcriptional activity, and function. LDN-212854 potently inhibits heterotopic ossification in an inducible transgenic mutant ALK2 mouse model of fibrodysplasia ossificans progressiva. These findings represent a significant step toward developing selective inhibitors targeting individual members of the highly homologous BMP type I receptor family. Such inhibitors would provide greater resolution as probes of physiologic function and improved selectivity against therapeutic targets.Keywords
This publication has 37 references indexed in Scilit:
- Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans ProgressivaJournal of Biological Chemistry, 2012
- Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in miceBlood, 2011
- Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammationBlood, 2011
- In Vivo Structure−Activity Relationship Study of Dorsomorphin Analogues Identifies Selective VEGF and BMP InhibitorsACS Chemical Biology, 2009
- Applications of small molecule BMP inhibitors in physiology and diseaseCytokine & Growth Factor Reviews, 2009
- BMP6 is a key endogenous regulator of hepcidin expression and iron metabolismNature Genetics, 2009
- BMP type I receptor inhibition reduces heterotopic ossificationNature Medicine, 2008
- Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Fibrodysplasia ossificans progressivaBest Practice & Research Clinical Rheumatology, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007